Expon I

Expon I is a venture capital firm based in Luxembourg, established in 2015. It focuses on investing in innovative companies across various sectors, including cybersecurity, fintech, big data, digital health, and next-generation media. The firm seeks opportunities that demonstrate the potential for significant growth and positive societal impact, specifically targeting businesses in Europe, North America, and Israel. By concentrating on sectors such as software, media, mobile technologies, and communication networks, Expon I aims to support and scale transformative ideas that align with its investment philosophy.

Marc Gendebien

Co-Founder and Managing Partner

Seunghun Park

Investment Analyst

Owen Reynolds

Venture Partner

Alain Rodermann

Co-Founder and Managing Partner

Jerome Wittamer

Co-Founder and Managing Partner

Past deals in Self-improvement

HelloBetter

Venture Round in 2025
HelloBetter is a pioneering company in the field of digital therapeutics focused on mental health. Founded in 2015 in Hamburg, Germany, the company offers a range of online psychological training programs designed to address issues such as stress, depression, anxiety, and sleep disorders. Its programs have been validated through 33 randomized controlled trials, and six of them have received approval as prescription digital therapeutics under Germany's DiGA framework, allowing access for over 73 million people at no cost. The company's mission is to empower individuals to manage their mental health in a self-determined manner, utilizing evidence-based approaches. In addition to its therapeutic programs, HelloBetter provides resources like blogs and articles related to psychological health. With recent funding aimed at expanding beyond the DACH region, HelloBetter continues to enhance access to effective digital mental health care on a global scale.

HelloBetter

Series A in 2023
HelloBetter is a pioneering company in the field of digital therapeutics focused on mental health. Founded in 2015 in Hamburg, Germany, the company offers a range of online psychological training programs designed to address issues such as stress, depression, anxiety, and sleep disorders. Its programs have been validated through 33 randomized controlled trials, and six of them have received approval as prescription digital therapeutics under Germany's DiGA framework, allowing access for over 73 million people at no cost. The company's mission is to empower individuals to manage their mental health in a self-determined manner, utilizing evidence-based approaches. In addition to its therapeutic programs, HelloBetter provides resources like blogs and articles related to psychological health. With recent funding aimed at expanding beyond the DACH region, HelloBetter continues to enhance access to effective digital mental health care on a global scale.

HelloBetter

Series A in 2022
HelloBetter is a pioneering company in the field of digital therapeutics focused on mental health. Founded in 2015 in Hamburg, Germany, the company offers a range of online psychological training programs designed to address issues such as stress, depression, anxiety, and sleep disorders. Its programs have been validated through 33 randomized controlled trials, and six of them have received approval as prescription digital therapeutics under Germany's DiGA framework, allowing access for over 73 million people at no cost. The company's mission is to empower individuals to manage their mental health in a self-determined manner, utilizing evidence-based approaches. In addition to its therapeutic programs, HelloBetter provides resources like blogs and articles related to psychological health. With recent funding aimed at expanding beyond the DACH region, HelloBetter continues to enhance access to effective digital mental health care on a global scale.

HelloBetter

Seed Round in 2021
HelloBetter is a pioneering company in the field of digital therapeutics focused on mental health. Founded in 2015 in Hamburg, Germany, the company offers a range of online psychological training programs designed to address issues such as stress, depression, anxiety, and sleep disorders. Its programs have been validated through 33 randomized controlled trials, and six of them have received approval as prescription digital therapeutics under Germany's DiGA framework, allowing access for over 73 million people at no cost. The company's mission is to empower individuals to manage their mental health in a self-determined manner, utilizing evidence-based approaches. In addition to its therapeutic programs, HelloBetter provides resources like blogs and articles related to psychological health. With recent funding aimed at expanding beyond the DACH region, HelloBetter continues to enhance access to effective digital mental health care on a global scale.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.